Summary
Anal melanoma represents only 1% of all melanomas. Owing to delayed diagnosis and early metastasis, the prognosis is uniformly poor. Sentinel lymph node (SLN) biopsy has become the preferred method of nodal staging method for cutaneous melanoma. The role of SLN biopsy for staging of anal melanoma remains unclear. We report a 39-yr-old Caucasian woman who presented with a history of chronic hemorrhoidal pain. She noted a pedunculated peri-anal mass associated with bleeding. Upon bipsy, the lesion was found to be a 6-mm thick primary anal melanoma. There was no evidence of metastatic disease on preoperative imaging studies. She underwent wide local excision of the peri-anal site of the primary melanoma and intraoperative lymphatic mapping with both isosulfan blue and filtered technetium sulfur colloid. With the guidance a lymphoscintigram, ipsilateral inguinal sentinel lymphadenectomy identified five nodes, all of which were both “hot” and blue. One node was found to have a 1-mm metastatic deposit. Subsequently, the patient was treated with adjuvant radiation therapy to the primary site as well as to the superficial and deep inguinal nodal basins. She also received four cycles of biochemotherapy. SLN biopsy appears feasible for staging the superficial inguinal lymph nodes in patients with anal melanoma. However, the impact of SLN biopsy, early detection of occult metastasis, and adjuvant systemic and radiation therapy on the long-term survival of patients with anal melanoma is uncertain.
Similar content being viewed by others
References
Weinstock MA. Epidemiology and prognosis of anorectal melanoma. Gastroenterology 1993;104:174–178.
Lew RA, Sober AJ, Cook N, et al. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol 1983;9:981–986.
Thibault D, Sagar P, Nivatvongs S Anorectal melanoma—an incurable disease? Dis Colon Rectum 1997;40:661–668.
Slingluff CL Jr, Vollmer RT, Seigler HFF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 1990;107:1–9.
Goldman S, Glimelius B, Pahlman L. Anorectal malignant melanoma in Sweden: report of 49 patients. Dis Colon Rectum 1990;33:374–377.
Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982;25:693–703.
Coit DG. Role of surgery for metastatic malignant melanoma: a review. Semin Surg Oncol 1993;9:239–245.
Chiu YS, Unni KK, Beart RW, Jr. Malignant melanoma of the anorectum. Dis Colon Rectum 1980;23:122–124.
Baas PC, Schraffordt Koops H, Hoekstra HJ, et al. Groin dissection in the treatment of lower-extremity melanoma: short-term and long-term morbidity. Arch Surg 1992; 127:281–286.
Yu LL, Flott TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617–627.
Gibbs JF, Huang PP, Zhang PJ, et al. Accuracy of pathologic techniques for the disgnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999;6:699–704.
Brady MS, Kavolius JP, Quan SH. Anorectal melanoma: a 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995;38:146–151.
Garnick M, Lokich JJ. Primary malignant melanoma of the rectum: rationale for conservative surgical management. J Surg Oncol 1978;10:529–531.
Soong SJ, Shaw HM, Balch CM, et al. Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg 1992;16:191–195.
Wanebo HJ, Woodruff JM, Farr GH, et al. Anorectal melanoma. Cancer 1981;47:1891–1900.
Legha SS, Ring S, Eton O, Bedikian A, Buzaid AC, Plager C, Papadopoulos N. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol 1998;16:1752–1759.
Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000;18:2444–2458.
Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 2001;19:2370–2380.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tien, H.Y., McMasters, K.M., Edwards, M.J. et al. Sentinel lymph node metastasis in anal melanoma. Int J Gastrointest Canc 32, 53–56 (2002). https://doi.org/10.1385/IJGC:32:1:53
Issue Date:
DOI: https://doi.org/10.1385/IJGC:32:1:53